Protocol to Support Breastfeeding for Postpartum Women and Mothers of Babies With Congenital Heart Disease
Breastfeeding, Congenital Heart Disease

About this trial
This is an interventional treatment trial for Breastfeeding focused on measuring breast milk, congenital heart desease, nutritional status, 6 months, call center
Eligibility Criteria
Inclusion Criteria: Infants diagnosed with congenital heart disease, The parents must have a cell phone enabled to receive video calls. Exclusion Criteria: Mothers carriers of the human immunodeficiency virus (HIV), Mothers users of medications without medical indication to initiate or maintain breastfeeding.
Sites / Locations
- Juliana CapriniRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Intervention Group
Control Group
Support for breastfeeding and depletion of breast milk throughout the 6 months. Free and professional support through monthly consultations and videos on the subject.
All mothers were followed up for 6 months and received a breastfeeding support booklet virtually, through a cell phone application. The booklet provides basic information about breastfeeding and possible complications. The recruited mothers also received a notebook to record the date, duration, volume and frequency of breastfeeding and/or milk collections, and the use of alternative routes such as a bottle, cup or enteral nutrition. At the initial visit, all mothers were given a standard measuring cup to measure the volume of milk used up in the household each day. In addition, all mothers received a call 7 days after delivery to apply the Portuguese version of the Breastfeeding Self-Efficacy Survey - Short Form: BSES-SF. This questionnaire was reapplied after 90 days.